Abstract P3-07-16: Pre-clinical study of amcenestrant and HER2-targeted therapies in HER2+/ER+ breast cancer cell line models

Authors: Amira F. Mahdi, Niall Ashfield, Neil T. Conlon, John Crown, Denis M. Collins

Published: 2023-03-02

DOI: 10.1158/1538-7445.sabcs22-p3-07-16

Source: Full article